Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 183 entries
Sorted by: Best Match Show Resources per page
In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014-2018.

Journal of global antimicrobial resistance

Gant V, Hussain A, Bain M, Longshaw C, Henriksen AS.
PMID: 34329792
J Glob Antimicrob Resist. 2021 Jul 27;27:1-11. doi: 10.1016/j.jgar.2021.07.014. Epub 2021 Jul 27.

OBJECTIVES: The prevalence of Gram-negative bacteria (GNB) demonstrating extensive, multiple antimicrobial resistance is increasing in England, leaving few treatment choices. Cefiderocol is a novel siderophore cephalosporin approved in Europe for the treatment of aerobic GNB infections in adults with...

Cite
Gant V, Hussain A, Bain M, et al. In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014-2018. J Glob Antimicrob Resist. 2021;27:1-11doi: 10.1016/j.jgar.2021.07.014.
Gant, V., Hussain, A., Bain, M., Longshaw, C., & Henriksen, A. S. (2021). In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014-2018. Journal of global antimicrobial resistance, 271-11. https://doi.org/10.1016/j.jgar.2021.07.014
Gant, Vanya, et al. "In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014-2018." Journal of global antimicrobial resistance vol. 27 (2021): 1-11. doi: https://doi.org/10.1016/j.jgar.2021.07.014
Gant V, Hussain A, Bain M, Longshaw C, Henriksen AS. In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014-2018. J Glob Antimicrob Resist. 2021 Jul 27;27:1-11. doi: 10.1016/j.jgar.2021.07.014. Epub 2021 Jul 27. PMID: 34329792.
Copy Download .nbib Format: NLM
Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM.

Clinical nutrition (Edinburgh, Scotland)

Henriksen C, Paur I, Pedersen A, Kværner AS, Ræder H, Henriksen HB, Bøhn SK, Wiedswang G, Blomhoff R.
PMID: 34999327
Clin Nutr. 2021 Dec 18;41(2):329-336. doi: 10.1016/j.clnu.2021.12.024. Epub 2021 Dec 18.

BACKGROUND & AIM: The Global Leadership Initiative on Malnutrition (GLIM) has suggested a process for the diagnosis of malnutrition. The process consists of applying an existing screening tool for malnutrition screening, followed by malnutrition diagnostics, and finally categorization of...

Cite
Henriksen C, Paur I, Pedersen A, et al. Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM. Clin Nutr. 2021;41(2):329-336doi: 10.1016/j.clnu.2021.12.024.
Henriksen, C., Paur, I., Pedersen, A., Kværner, A. S., Ræder, H., Henriksen, H. B., Bøhn, S. K., Wiedswang, G., & Blomhoff, R. (2021). Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM. Clinical nutrition (Edinburgh, Scotland), 41(2), 329-336. https://doi.org/10.1016/j.clnu.2021.12.024
Henriksen, Christine, et al. "Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM." Clinical nutrition (Edinburgh, Scotland) vol. 41,2 (2021): 329-336. doi: https://doi.org/10.1016/j.clnu.2021.12.024
Henriksen C, Paur I, Pedersen A, Kværner AS, Ræder H, Henriksen HB, Bøhn SK, Wiedswang G, Blomhoff R. Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM. Clin Nutr. 2021 Dec 18;41(2):329-336. doi: 10.1016/j.clnu.2021.12.024. Epub 2021 Dec 18. PMID: 34999327.
Copy Download .nbib Format: NLM
Erratum to: Childhood overweight and obesity and timing of puberty in boys and girls: cohort and sibling-matched analyses.

International journal of epidemiology

Brix N, Ernst A, Lauridsen LLB, Parner ET, Arah OA, Olsen J, Henriksen TB, Ramlau-Hansen CH.
PMID: 34244765
Int J Epidemiol. 2021 Jul 09;50(3):1047. doi: 10.1093/ije/dyab075.

No abstract available.

Cite
Brix N, Ernst A, Lauridsen LLB, et al. Erratum to: Childhood overweight and obesity and timing of puberty in boys and girls: cohort and sibling-matched analyses. Int J Epidemiol. 2021;50(3):1047doi: 10.1093/ije/dyab075.
Brix, N., Ernst, A., Lauridsen, L. L. B., Parner, E. T., Arah, O. A., Olsen, J., Henriksen, T. B., & Ramlau-Hansen, C. H. (2021). Erratum to: Childhood overweight and obesity and timing of puberty in boys and girls: cohort and sibling-matched analyses. International journal of epidemiology, 50(3), 1047. https://doi.org/10.1093/ije/dyab075
Brix, Nis, et al. "Erratum to: Childhood overweight and obesity and timing of puberty in boys and girls: cohort and sibling-matched analyses." International journal of epidemiology vol. 50,3 (2021): 1047. doi: https://doi.org/10.1093/ije/dyab075
Brix N, Ernst A, Lauridsen LLB, Parner ET, Arah OA, Olsen J, Henriksen TB, Ramlau-Hansen CH. Erratum to: Childhood overweight and obesity and timing of puberty in boys and girls: cohort and sibling-matched analyses. Int J Epidemiol. 2021 Jul 09;50(3):1047. doi: 10.1093/ije/dyab075. PMID: 34244765; PMCID: PMC8271182.
Copy Download .nbib Format: NLM
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Letter.

Clinical cancer research : an official journal of the American Association for Cancer Research

Reinert T, Henriksen TV, Aleshin A, Zimmermann B, Andersen CL.
PMID: 34853074
Clin Cancer Res. 2021 Dec 01;27(23):6613. doi: 10.1158/1078-0432.CCR-21-2735.

No abstract available.

Cite
Reinert T, Henriksen TV, Aleshin A, et al. Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Letter. Clin Cancer Res. 2021;27(23):6613doi: 10.1158/1078-0432.CCR-21-2735.
Reinert, T., Henriksen, T. V., Aleshin, A., Zimmermann, B., & Andersen, C. L. (2021). Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Letter. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(23), 6613. https://doi.org/10.1158/1078-0432.CCR-21-2735
Reinert, Thomas, et al. "Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Letter." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,23 (2021): 6613. doi: https://doi.org/10.1158/1078-0432.CCR-21-2735
Reinert T, Henriksen TV, Aleshin A, Zimmermann B, Andersen CL. Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Letter. Clin Cancer Res. 2021 Dec 01;27(23):6613. doi: 10.1158/1078-0432.CCR-21-2735. PMID: 34853074.
Copy Download .nbib Format: NLM
Neurological Outcome Following Newborn Encephalopathy With and Without Perinatal Infection: A Systematic Review.

Frontiers in pediatrics

Andersen M, Pedersen MV, Andelius TCK, Kyng KJ, Henriksen TB.
PMID: 34988041
Front Pediatr. 2021 Dec 20;9:787804. doi: 10.3389/fped.2021.787804. eCollection 2021.

No abstract available.

Cite
Andersen M, Pedersen MV, Andelius TCK, et al. Neurological Outcome Following Newborn Encephalopathy With and Without Perinatal Infection: A Systematic Review. Front Pediatr. 2021;9:787804doi: 10.3389/fped.2021.787804.
Andersen, M., Pedersen, M. V., Andelius, T. C. K., Kyng, K. J., & Henriksen, T. B. (2021). Neurological Outcome Following Newborn Encephalopathy With and Without Perinatal Infection: A Systematic Review. Frontiers in pediatrics, 9787804. https://doi.org/10.3389/fped.2021.787804
Andersen, Mads, et al. "Neurological Outcome Following Newborn Encephalopathy With and Without Perinatal Infection: A Systematic Review." Frontiers in pediatrics vol. 9 (2021): 787804. doi: https://doi.org/10.3389/fped.2021.787804
Andersen M, Pedersen MV, Andelius TCK, Kyng KJ, Henriksen TB. Neurological Outcome Following Newborn Encephalopathy With and Without Perinatal Infection: A Systematic Review. Front Pediatr. 2021 Dec 20;9:787804. doi: 10.3389/fped.2021.787804. eCollection 2021. PMID: 34988041; PMCID: PMC8721111.
Copy Download .nbib Format: NLM
Axion Dark Matter Experiment: Detailed design and operations.

The Review of scientific instruments

Khatiwada R, Bowring D, Chou AS, Sonnenschein A, Wester W, Mitchell DV, Braine T, Bartram C, Cervantes R, Crisosto N, Du N, Rosenberg LJ, Rybka G, Yang J, Will D, Kimes S, Carosi G, Woollett N, Durham S, Duffy LD, Bradley R, Boutan C, Jones M, LaRoque BH, Oblath NS, Taubman MS, Tedeschi J, Clarke J, Dove A, Hashim A, Siddiqi I, Stevenson N, Eddins A, O'Kelley SR, Nawaz S, Agrawal A, Dixit AV, Gleason JR, Jois S, Sikivie P, Sullivan NS, Tanner DB, Solomon JA, Lentz E, Daw EJ, Perry MG, Buckley JH, Harrington PM, Henriksen EA, Murch KW, Hilton GC.
PMID: 34972408
Rev Sci Instrum. 2021 Dec 01;92(12):124502. doi: 10.1063/5.0037857.

Axion dark matter experiment ultra-low noise haloscope technology has enabled the successful completion of two science runs (1A and 1B) that looked for dark matter axions in the 2.66-3.1 μeV mass range with Dine-Fischler-Srednicki-Zhitnisky sensitivity [Du et al., Phys....

Cite
Khatiwada R, Bowring D, Chou AS, et al. Axion Dark Matter Experiment: Detailed design and operations. Rev Sci Instrum. 2021;92(12):124502doi: 10.1063/5.0037857.
Khatiwada, R., Bowring, D., Chou, A. S., Sonnenschein, A., Wester, W., Mitchell, D. V., Braine, T., Bartram, C., Cervantes, R., Crisosto, N., Du, N., Rosenberg, L. J., Rybka, G., Yang, J., Will, D., Kimes, S., Carosi, G., Woollett, N., Durham, S., Duffy, L. D., Bradley, R., Boutan, C., Jones, M., LaRoque, B. H., Oblath, N. S., Taubman, M. S., Tedeschi, J., Clarke, J., Dove, A., Hashim, A., Siddiqi, I., Stevenson, N., Eddins, A., O'Kelley, S. R., Nawaz, S., Agrawal, A., Dixit, A. V., Gleason, J. R., Jois, S., Sikivie, P., Sullivan, N. S., Tanner, D. B., Solomon, J. A., Lentz, E., Daw, E. J., Perry, M. G., Buckley, J. H., Harrington, P. M., Henriksen, E. A., Murch, K. W., & Hilton, G. C. (2021). Axion Dark Matter Experiment: Detailed design and operations. The Review of scientific instruments, 92(12), 124502. https://doi.org/10.1063/5.0037857
Khatiwada, R, et al. "Axion Dark Matter Experiment: Detailed design and operations." The Review of scientific instruments vol. 92,12 (2021): 124502. doi: https://doi.org/10.1063/5.0037857
Khatiwada R, Bowring D, Chou AS, Sonnenschein A, Wester W, Mitchell DV, Braine T, Bartram C, Cervantes R, Crisosto N, Du N, Rosenberg LJ, Rybka G, Yang J, Will D, Kimes S, Carosi G, Woollett N, Durham S, Duffy LD, Bradley R, Boutan C, Jones M, LaRoque BH, Oblath NS, Taubman MS, Tedeschi J, Clarke J, Dove A, Hashim A, Siddiqi I, Stevenson N, Eddins A, O'Kelley SR, Nawaz S, Agrawal A, Dixit AV, Gleason JR, Jois S, Sikivie P, Sullivan NS, Tanner DB, Solomon JA, Lentz E, Daw EJ, Perry MG, Buckley JH, Harrington PM, Henriksen EA, Murch KW, Hilton GC. Axion Dark Matter Experiment: Detailed design and operations. Rev Sci Instrum. 2021 Dec 01;92(12):124502. doi: 10.1063/5.0037857. PMID: 34972408.
Copy Download .nbib Format: NLM
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications.

Parkinsonism & related disorders

Antonini A, Odin P, Schmidt P, Cubillos F, Standaert DG, Henriksen T, Jimenez-Shahed J, Alobaidi A, Jalundhwala YJ, Bao Y, Zamudio J, Parra JC, Kukreja P, Onuk K, Skalicky AM, Kleinman L, Jones E, Metz S, Fernandez HH.
PMID: 34695657
Parkinsonism Relat Disord. 2021 Nov;92:59-66. doi: 10.1016/j.parkreldis.2021.10.009. Epub 2021 Oct 13.

INTRODUCTION: Making Informed Decisions to Aid Timely Management of Parkinson's Disease (MANAGE-PD) is a clinician-reported tool designed to facilitate timely identification and management of patients with advancing Parkinson's disease (PD) with suboptimal symptom control while on standard therapy. The...

Cite
Antonini A, Odin P, Schmidt P, et al. Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. Parkinsonism Relat Disord. 2021;92:59-66doi: 10.1016/j.parkreldis.2021.10.009.
Antonini, A., Odin, P., Schmidt, P., Cubillos, F., Standaert, D. G., Henriksen, T., Jimenez-Shahed, J., Alobaidi, A., Jalundhwala, Y. J., Bao, Y., Zamudio, J., Parra, J. C., Kukreja, P., Onuk, K., Skalicky, A. M., Kleinman, L., Jones, E., Metz, S., & Fernandez, H. H. (2021). Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. Parkinsonism & related disorders, 9259-66. https://doi.org/10.1016/j.parkreldis.2021.10.009
Antonini, Angelo, et al. "Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications." Parkinsonism & related disorders vol. 92 (2021): 59-66. doi: https://doi.org/10.1016/j.parkreldis.2021.10.009
Antonini A, Odin P, Schmidt P, Cubillos F, Standaert DG, Henriksen T, Jimenez-Shahed J, Alobaidi A, Jalundhwala YJ, Bao Y, Zamudio J, Parra JC, Kukreja P, Onuk K, Skalicky AM, Kleinman L, Jones E, Metz S, Fernandez HH. Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. Parkinsonism Relat Disord. 2021 Nov;92:59-66. doi: 10.1016/j.parkreldis.2021.10.009. Epub 2021 Oct 13. PMID: 34695657.
Copy Download .nbib Format: NLM
Longer retrieval distances to the automated external defibrillator reduces survival after out-of-hospital cardiac arrest.

Resuscitation

Sarkisian L, Mickley H, Schakow H, Gerke O, Starck SM, Jensen JJ, Møller JE, Jørgensen G, Henriksen FL.
PMID: 34767901
Resuscitation. 2021 Nov 09;170:44-52. doi: 10.1016/j.resuscitation.2021.11.001. Epub 2021 Nov 09.

AIMS: To evaluate and compare survival after out-of-hospital (OHCA), where an automated external defibrillator (AED) was used, in densely, moderately and thinly populated areas. Also, to evaluate the association between AED retrieval distance and survival after OHCA.METHODS: From 2014...

Cite
Sarkisian L, Mickley H, Schakow H, et al. Longer retrieval distances to the automated external defibrillator reduces survival after out-of-hospital cardiac arrest. Resuscitation. 2021;170:44-52doi: 10.1016/j.resuscitation.2021.11.001.
Sarkisian, L., Mickley, H., Schakow, H., Gerke, O., Starck, S. M., Jensen, J. J., Møller, J. E., Jørgensen, G., & Henriksen, F. L. (2021). Longer retrieval distances to the automated external defibrillator reduces survival after out-of-hospital cardiac arrest. Resuscitation, 17044-52. https://doi.org/10.1016/j.resuscitation.2021.11.001
Sarkisian, Laura, et al. "Longer retrieval distances to the automated external defibrillator reduces survival after out-of-hospital cardiac arrest." Resuscitation vol. 170 (2021): 44-52. doi: https://doi.org/10.1016/j.resuscitation.2021.11.001
Sarkisian L, Mickley H, Schakow H, Gerke O, Starck SM, Jensen JJ, Møller JE, Jørgensen G, Henriksen FL. Longer retrieval distances to the automated external defibrillator reduces survival after out-of-hospital cardiac arrest. Resuscitation. 2021 Nov 09;170:44-52. doi: 10.1016/j.resuscitation.2021.11.001. Epub 2021 Nov 09. PMID: 34767901.
Copy Download .nbib Format: NLM
Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis.

Pharmacoepidemiology and drug safety

Lund LC, Højlund M, Henriksen DP, Hallas J, Kristensen KB.
PMID: 33881179
Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1391-1395. doi: 10.1002/pds.5252. Epub 2021 May 13.

PURPOSE: Sodium-glucose cotransporter-2 inhibitors (SGLT2-I) are frequently used in type 2 diabetes and have recently been associated with lower rates of gout compared to glucagon-like peptide-1 receptor agonists (GLP1-RA). Our objective was to assess the association between SGLT2-I initiation...

Cite
Lund LC, Højlund M, Henriksen DP, et al. Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis. Pharmacoepidemiol Drug Saf. 2021;30(10):1391-1395doi: 10.1002/pds.5252.
Lund, L. C., Højlund, M., Henriksen, D. P., Hallas, J., & Kristensen, K. B. (2021). Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis. Pharmacoepidemiology and drug safety, 30(10), 1391-1395. https://doi.org/10.1002/pds.5252
Lund, Lars Christian, et al. "Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis." Pharmacoepidemiology and drug safety vol. 30,10 (2021): 1391-1395. doi: https://doi.org/10.1002/pds.5252
Lund LC, Højlund M, Henriksen DP, Hallas J, Kristensen KB. Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis. Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1391-1395. doi: 10.1002/pds.5252. Epub 2021 May 13. PMID: 33881179.
Copy Download .nbib Format: NLM
The Danish in-hospital cardiac arrest registry (DANARREST).

Clinical epidemiology

Andersen LW, Østergaard JN, Antonsen S, Weis A, Rosenberg J, Henriksen FL, Sandgaard NC, Skjærbæk C, Johnsen SP, Kirkegaard H.
PMID: 31191032
Clin Epidemiol. 2019 May 13;11:397-402. doi: 10.2147/CLEP.S201074. eCollection 2019.

No abstract available.

Cite
Andersen LW, Østergaard JN, Antonsen S, et al. The Danish in-hospital cardiac arrest registry (DANARREST). Clin Epidemiol. 2019;11:397-402doi: 10.2147/CLEP.S201074.
Andersen, L. W., Østergaard, J. N., Antonsen, S., Weis, A., Rosenberg, J., Henriksen, F. L., Sandgaard, N. C., Skjærbæk, C., Johnsen, S. P., & Kirkegaard, H. (2019). The Danish in-hospital cardiac arrest registry (DANARREST). Clinical epidemiology, 11397-402. https://doi.org/10.2147/CLEP.S201074
Andersen, Lars W, et al. "The Danish in-hospital cardiac arrest registry (DANARREST)." Clinical epidemiology vol. 11 (2019): 397-402. doi: https://doi.org/10.2147/CLEP.S201074
Andersen LW, Østergaard JN, Antonsen S, Weis A, Rosenberg J, Henriksen FL, Sandgaard NC, Skjærbæk C, Johnsen SP, Kirkegaard H. The Danish in-hospital cardiac arrest registry (DANARREST). Clin Epidemiol. 2019 May 13;11:397-402. doi: 10.2147/CLEP.S201074. eCollection 2019. PMID: 31191032; PMCID: PMC6526176.
Copy Download .nbib Format: NLM
Data, Temporary Monopolies and Biosimilar Development.

Journal of law and medicine

Henriksen T.
PMID: 34907685
J Law Med. 2021 Dec;28(4):1048-1065.

Biosimilars facilitate access to the lifesaving and life-changing effects of biologics through reduced prices. Against the increasing uptake of biosimilars in coming years it is important to consider some of the regulatory levers governments use to promote biosimilar uptake...

Cite
Henriksen T. Data, Temporary Monopolies and Biosimilar Development. J Law Med. 2021;28(4):1048-1065
Henriksen, T. (2021). Data, Temporary Monopolies and Biosimilar Development. Journal of law and medicine, 28(4), 1048-1065.
Henriksen, Teddy. "Data, Temporary Monopolies and Biosimilar Development." Journal of law and medicine vol. 28,4 (2021): 1048-1065.
Henriksen T. Data, Temporary Monopolies and Biosimilar Development. J Law Med. 2021 Dec;28(4):1048-1065. PMID: 34907685.
Copy Download .nbib Format: NLM
Nationwide study on trends in unplanned hospital attendance and deaths during the 7 weeks after the onset of the COVID-19 pandemic in Denmark.

BMJ quality & safety

Bogh SB, Fløjstrup M, Nissen SK, Hanson S, Bech M, Johnsen SP, Kristensen MR, Laugesen LE, Søndergaard J, Folkestad L, Christensen EF, Henriksen DP, Hsia RY, Graham CA, Lindskou TA, Byg KE, Søvsø MB, Laugesen H, Hallas P, Mikkelsen S, Olsen KR, Thygesen LC, Gamst-Jensen H, Brabrand M.
PMID: 33952687
BMJ Qual Saf. 2021 Dec;30(12):986-995. doi: 10.1136/bmjqs-2020-012144. Epub 2021 May 05.

BACKGROUND: The impact of a pandemic on unplanned hospital attendance has not been extensively examined. The aim of this study is to report the nationwide consequences of the COVID-19 pandemic on unplanned hospital attendances in Denmark for 7 weeks...

Cite
Bogh SB, Fløjstrup M, Nissen SK, et al. Nationwide study on trends in unplanned hospital attendance and deaths during the 7 weeks after the onset of the COVID-19 pandemic in Denmark. BMJ Qual Saf. 2021;30(12):986-995doi: 10.1136/bmjqs-2020-012144.
Bogh, S. B., Fløjstrup, M., Nissen, S. K., Hanson, S., Bech, M., Johnsen, S. P., Kristensen, M. R., Laugesen, L. E., Søndergaard, J., Folkestad, L., Christensen, E. F., Henriksen, D. P., Hsia, R. Y., Graham, C. A., Lindskou, T. A., Byg, K. E., Søvsø, M. B., Laugesen, H., Hallas, P., Mikkelsen, S., Olsen, K. R., Thygesen, L. C., Gamst-Jensen, H., & Brabrand, M. (2021). Nationwide study on trends in unplanned hospital attendance and deaths during the 7 weeks after the onset of the COVID-19 pandemic in Denmark. BMJ quality & safety, 30(12), 986-995. https://doi.org/10.1136/bmjqs-2020-012144
Bogh, Søren Bie, et al. "Nationwide study on trends in unplanned hospital attendance and deaths during the 7 weeks after the onset of the COVID-19 pandemic in Denmark." BMJ quality & safety vol. 30,12 (2021): 986-995. doi: https://doi.org/10.1136/bmjqs-2020-012144
Bogh SB, Fløjstrup M, Nissen SK, Hanson S, Bech M, Johnsen SP, Kristensen MR, Laugesen LE, Søndergaard J, Folkestad L, Christensen EF, Henriksen DP, Hsia RY, Graham CA, Lindskou TA, Byg KE, Søvsø MB, Laugesen H, Hallas P, Mikkelsen S, Olsen KR, Thygesen LC, Gamst-Jensen H, Brabrand M. Nationwide study on trends in unplanned hospital attendance and deaths during the 7 weeks after the onset of the COVID-19 pandemic in Denmark. BMJ Qual Saf. 2021 Dec;30(12):986-995. doi: 10.1136/bmjqs-2020-012144. Epub 2021 May 05. PMID: 33952687.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 183 entries